Galactitol,1,6-dibromo-1,6-dideoxy- cas no:10318-26-0

NameGalactitol,1,6-dibromo-1,6-dideoxy-
CAS10318-26-0
Synonyms1,6-Dibromo-1,6-dideoxy-D-dulcitol;1,6-Dibromo-1,6-dideoxydulcitol; 1,6-Dibromodideoxydulcitol;1,6-Dibromodulcitol; DBD; DBD (alcohol); Dibromdulcit; Dibromodulcitol;Dibromogalactitol; Elobromol; Mitolactol; NCI C04795; NSC 104800
EINECS(EC#)207-676-8
Molecular FormulaC6H12 Br2 O4
Molecular Weight308.00

refractive index1.622

Safety

Poison by ingestion. Moderately toxic by intraperitoneal route. Questionable carcinogen with experimental carcinogenic, neoplastigenic, and tumorigenic data. Human mutation data reported. An anti-cancer agent taken orally. When heated to decomposition it emits very toxic fumes of Br⁻.

1.		mmo-sat 100 µg/plate		CRNGDP    Carcinogenesis. 3 (1982),333.
2.		dnd-rat-ipr 110 mg/kg		CBINA8    Chemico-Biological Interactions. 47 (1983),133.
3.		bfa rat/sat 450 mg/kg		CRNGDP    Carcinogenesis. 3 (1982),333.
4.		sce-ham:oth 5500 ng/L		CNREA8    Cancer Research. 43 (1983),4530.
5.		dnd-mam:lym 150 mmol/L		CBINA8    Chemico-Biological Interactions. 47 (1983),133.
6.		orl-rat LD50:1000 mg/kg		CCROBU    Cancer Chemotherapy Reports, Part 1. 56 (1972),593.
7.		ipr-rat LD50:470 mg/kg		CCROBU    Cancer Chemotherapy Reports, Part 1. 56 (1972),593.
8.		orl-mus LD50:1238 mg/kg		NCISP*    National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 .
9.		ipr-mus LD50:550 mg/kg		ARZNAD    Arzneimittel-Forschung. Drug Research. 17 (1967),145.
10.		orl-rbt LD50:300 mg/kg		CCROBU    Cancer Chemotherapy Reports, Part 1. 56 (1972),593.